Kevin Stefanski

Discovery of <i>N</i>-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily

Gretchen M. Schroeder, Yongmi An, Zhen‐Wei Cai et al. · Journal of Medicinal Chemistry · 2009 · 277 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Enhanced Oral Bioavailability of a Poorly Water Soluble Drug PNU‐91325 by Supersaturatable Formulations

Ping Gao, Michael E. Guyton, Tiehua Huang et al. · Drug Development and Industrial Pharmacy · 2004 · 207 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Drug–Polymer–Water Interaction and Its Implication for the Dissolution Performance of Amorphous Solid Dispersions

Yuejie Chen, Chengyu Liu, Zhen Chen et al. · Molecular Pharmaceutics · 2014 · 170 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction

Yuejie Chen, Shujing Wang, Shan Wang et al. · Pharmaceutical Research · 2016 · 115 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Discovery of a 2,4-Disubstituted Pyrrolo[1,2-<i>f</i>][1,2,4]triazine Inhibitor (BMS-754807) of Insulin-like Growth Factor Receptor (IGF-1R) Kinase in Clinical Development

Mark D. Wittman, Joan M. Carboni, Yang Zheng et al. · Journal of Medicinal Chemistry · 2009 · 94 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9